Emerging properties of cannabinoid medicines in management of multiple sclerosis

被引：60
|
作者：
Pryce, G [1 ]
Baker, D [1 ]
机构：
[1] UCL, Inst Neurol, Dept Neuroinflammat, London WC1N 1PJ, England
来源：
TRENDS IN NEUROSCIENCES | 2005年 / 28卷 / 05期
关键词：
D O I：
10.1016/j.tins.2005.03.006
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Use of cannabis as a medicine for numerous conditions has a well-documented history stretching back thousands of years. With the identification of an endogenous system of receptors and ligands in recent years, abundant experimental data have reinforced the anecdotal claims of people who perceive medicinal benefit from the currently illegal consumption of cannabis. This, combined with data from recent clinical trials, points to the prospect of cannabis as a medication in the treatment of multiple sclerosis and numerous other medical conditions.
引用
收藏
页码：272 / 276
页数：5
相关论文
共 50 条
  • [21] Emerging therapies for multiple sclerosis
    WeinstockGuttman, B
    Cohen, JA
    NEUROLOGIST, 1996, 2 (06) : 342 - 355
  • [22] Emerging therapies for multiple sclerosis
    Muraro, Paolo A.
    Bielekova, Bibiana
    NEUROTHERAPEUTICS, 2007, 4 (04) : 676 - 692
  • [23] Medicines for multiple sclerosis - addition - EML and EMLc
    SELECTION AND USE OF ESSENTIAL MEDICINES: REPORT OF THE WHO EXPERT COMMITTEE ON SELECTION AND USE OF ESSENTIAL MEDICINES, 2019 (INCLUDING THE 21ST WHO MODEL LIST OF ESSENTIAL MEDICINES AND THE 7TH WHO MODEL LIST OF ESSENTIAL MEDICINES FOR CHILDREN), 2019, 1021 : 188 - 201
  • [24] Immunomodulatory medicines for multiple sclerosis: Progress and prospects
    Palmer, Alan M.
    DRUG DEVELOPMENT RESEARCH, 2011, 72 (08) : 664 - 673
  • [25] Experimental medicines in multiple sclerosis and compassionate use
    Kelly, J. S.
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2009, 39 (01): : 35 - 37
  • [26] Cannabinoid system and neuroinflammation:: Therapeutic perspectives in multiple sclerosis
    Mestre, L.
    Correa, F.
    Docagne, F.
    Clemente, D.
    Ortega-Gutierrez, S.
    Arevalo-Martin, A.
    Molina-Holgado, E.
    Borrell, J.
    Guaza, C.
    REVISTA DE NEUROLOGIA, 2006, 43 (09) : 541 - 548
  • [27] Targeting Toll-like receptors: Emerging therapeutics for multiple sclerosis management
    Gambuzza, M.
    Licata, N.
    Palella, E.
    Celi, D.
    Cuzzola, V. Foti
    Italiano, D.
    Marino, S.
    Bramanti, P.
    JOURNAL OF NEUROIMMUNOLOGY, 2011, 239 (1-2) : 1 - 12
  • [28] Emerging effects of comorbidities on multiple sclerosis
    Morrie, Ruth Ann
    Horwitz, Ralph I.
    LANCET NEUROLOGY, 2010, 9 (08): : 820 - 828
  • [29] Emerging oral therapies for multiple sclerosis
    Cohen, B. A.
    Rieckmann, P.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (11) : 1922 - 1930
  • [30] Emerging multiple sclerosis oral therapies
    Rammohan, Kottil W.
    Shoemaker, Jennifer
    NEUROLOGY, 2010, 74 (01) : S47 - S53
12345